Your Client Rank:
Loading...
99
Updated 28-Apr-2026
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Ascendis | 34.9% | 0.3% | -17.6% | -21.9% | | | | |
| Lilly | 14.3% | 0.0% | -2.7% | -7.4% | 4.1% | -1.0% | 19.9% | 20.2% |
| Vertex | 10.7% | 0.4% | -2.2% | -5.2% | 3.7% | 3.0% | 12.9% | 13.2% |
| Chugai | 8.2% | 1.6% | -3.2% | -2.2% | 2.7% | -0.4% | 11.9% | 11.7% |
| Daiichi | 8.0% | 1.4% | 2.3% | -3.0% | 4.4% | 1.3% | 12.2% | 11.7% |
| Regeneron | 7.8% | 0.2% | -2.4% | -2.2% | 4.9% | 4.2% | 11.5% | 11.6% |
| Astra | 6.7% | 0.3% | -2.7% | -1.8% | 4.8% | 1.6% | 11.4% | 11.4% |
| Eisai | 6.7% | -1.1% | -3.6% | -5.3% | 11.6% | -0.8% | 17.7% | 18.1% |
| JNJ | 6.5% | 0.4% | -2.3% | -1.5% | 3.2% | 1.0% | 9.4% | 9.6% |
| AbbVie | 5.8% | -0.1% | -2.6% | -9.1% | 5.8% | -1.4% | 13.5% | 13.9% |
| Sanofi | 5.1% | 0.5% | -1.7% | -2.2% | 3.6% | 0.3% | 7.7% | 8.9% |
| Novartis | 4.4% | 0.2% | -1.2% | 0.0% | 0.7% | 0.7% | 5.1% | 6.1% |
| Gilead | 4.1% | 0.0% | -0.9% | -4.5% | 2.3% | 1.4% | 7.0% | 7.2% |
| Shionogi | 4.0% | -1.1% | 1.6% | -1.7% | -3.3% | 1.6% | -2.5% | -2.8% |
| Roche | 3.5% | 0.3% | -1.4% | -0.8% | 2.2% | 1.0% | 6.4% | 6.2% |
| Amgen | 3.2% | 0.0% | -0.1% | -1.3% | 0.5% | 1.5% | 4.6% | 5.3% |
| Novo | 3.0% | 0.2% | -0.3% | -1.1% | 1.8% | 0.1% | 2.7% | 3.6% |
| Merck | 2.7% | -0.1% | -1.0% | 0.2% | 0.2% | 2.8% | 2.4% | 3.0% |
| Bayer | 2.5% | | | | | | | |
| Takeda | 2.3% | 0.1% | -0.6% | 1.2% | 12.5% | -8.7% | 3.3% | 4.3% |
| Teva | 2.2% | 1.0% | -1.4% | -0.8% | 3.3% | 1.1% | 7.4% | 6.0% |
| Glaxo | 1.8% | 0.1% | -0.8% | -0.3% | 0.5% | 0.6% | 3.3% | 3.5% |
| Biogen | -1.2% | 0.2% | 1.0% | -3.6% | 1.1% | 1.6% | 2.5% | 1.9% |
| Lundbeck | -2.4% | -0.2% | 0.9% | 4.5% | -2.2% | -2.6% | -5.8% | -4.6% |
| Pfizer | -4.1% | -0.4% | 0.8% | 1.7% | -1.2% | 4.8% | -6.7% | -6.7% |
| Astellas | -4.3% | -0.6% | -1.9% | 4.7% | -1.3% | -1.3% | -6.8% | -6.7% |
| Bristol | -5.0% | 0.6% | 4.1% | -3.6% | 1.5% | -0.2% | -5.4% | -4.6% |
| Neurocrine | | | | | | | | |
| EU Major | 4.0% | 0.2% | -1.2% | -0.8% | 2.6% | 0.8% | | |
| Other EU | 8.9% | 0.4% | -5.8% | -5.3% | 20.8% | -16.3% | 31.7% | |
| US Major | 4.7% | 0.2% | -1.5% | -3.8% | 3.4% | 0.9% | 8.2% | 12.6% |
| US Big Biotech | 4.8% | 0.2% | -1.2% | -2.6% | 2.2% | 2.1% | 7.6% | 9.2% |
| Other US | 2.2% | 1.0% | -1.4% | -0.8% | 3.3% | 1.1% | 7.4% | 6.0% |
| Japanese | 3.5% | 0.3% | -0.6% | -0.3% | 4.7% | -1.1% | 5.1% | 6.2% |
